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Abstract
The formal synthesis of (+)-sorangicin A was completed by two independent routes. Both
approaches feature a cross metathesis reaction to form the C29-C30 bond to arrive at the bicyclic
ether/tetrahydropyran fragment. Formation of the C15-C16 olefin to unite the dihydropyran
fragment with the rest of the molecule was achieved by either a cross metathesis reaction or a
Julia-Kocienski olefination.
(+)-Sorangicin A (1) was isolated in 1985 from the gliding bacterium Sorangium cellulosum
by Höfle and Reichenbach.1 It exhibits potent antibiotic activity against both Gram-positive
(MIC 0.01-0.1 μg/mL) and Gram-negative bacteria (MIC 3-30 μg/mL) through inhibition of
RNA polymerase in vivo.2 Sorangicin A is comprised of several synthetically challenging
structural features including the C30-C37 signature bicyclic ether, C21-C29 tetra-substituted
tetrahydropyran, and C1-C15 tri-substituted dihydropyran, all of which are embedded in a
31-membered lactone. Additionally, the macrocyclic skeleton is highly unsaturated featuring
a unique and highly sensitive (Z,Z,E)-trienoate linkage to which the instability of the natural
product towards several reagents has been attributed.3 The potent antibiotic activity and
complex structure of (+)-sorangicin A have prompted several synthetic approaches4
culminating in a total synthesis by the Smith group.5
Herein we describe two approaches towards C1-C38 fragment 2, an advanced intermediate
in Smith's total synthesis of (+)-sorangicin A (1). Our synthetic approach involved the
preparation of three orthogonally differentiated core fragments: bicyclic ether 3,
tetrahydropyran 4, and dihydropyran 5 or 6, which would allow us to investigate a variety of
coupling strategies (Scheme 1).
Our initial retrosynthetic plan involved the use of a cross metathesis reaction to form both
the C29-C30 and C15-C16 olefins; however, a low yield for the second cross metathesis
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reaction prompted investigation of a Julia-Kocienski olefination, also used in Smith's
synthesis, to form the C15-C16 bond.
Initial efforts were focused on the synthesis of tetrahydropyran (THP) 4 (Scheme 2). We
envisioned that this fragment could be prepared via an acid-catalyzed epoxide-opening
cascade, similar to our previously reported route used for the preparation of bicyclic ether
3.6 To begin, a cross metathesis reaction7 between known aldehyde 78 and diacetate 8 was
performed with Grubbs second generation catalyst (G2) to deliver cross metathesis adduct 9
in 67% yield. Subsequent Brown asymmetric allylation9 of aldehyde 9 with (+)-Ipc2B-allyl
gave rise to diol 10 in 86% yield after basic workup. Allylic alcohol 10 was employed in a
Sharpless asymmetric epoxidation reaction,10 which upon acidic workup of the intermediate
epoxy alcohol, initiated the epoxide-opening/cyclization to arrive at the cyclic ether. Finally,
protection of the diol as the bis-triethylsilyl (TES) ether delivered THP 4 in 62% yield over
the two step sequence.
With a route towards both THP 4 and bicyclic ether 3, cross metathesis to form the C29-C30
bond was explored. The desired cross metathesis substrate, bicyclic ether 11, was prepared
by a three step sequence of acylation, ozonolysis, and methylenation11 from previously
prepared bicyclic ether 36 in 85% yield (Scheme 3). Elaboration of THP 4 to incorporate the
C16-C20 fragment was also carried out prior to the key cross metathesis reaction. Toward
this end, selective cleavage and oxidation of the primary TES ether was realized upon
subjection of THP 4 to modified Swern conditions.12 The vinyl zinc species generated in
situ from C16-C20 vinyl iodide 12, underwent a Felkin-Anh controlled addition to the
aldehyde to introduce the C21 stereocenter as an 8:1 mixture of separable diastereomers.
Subsequent conversion of the 1,2-diol to the acetonide by a two step sequence afforded
dihydropyran 13 in 66% yield over the four steps.
The cross metathesis reaction between bicyclic ether 11 and THP fragment 13 was
accomplished in 40% yield, 69% based on recovered bicyclic ether 11, upon addition of
THP 13 dropwise over several hours to a solution of bicyclic ether 11 and Grubbs 2nd
generation catalyst. Removal of the TIPS protecting group, followed by Lindlar reduction of
the alkyne,13 and subsequent adjustment of the C25 and C37 protecting groups provided
terminal olefin 16 in 55% yield over the six step sequence.
Having developed an efficient route towards bicyclic ether THP/fragment 16, synthesis and
incorporation of the dihydropyran (DHP) fragment was next explored. The synthesis of the
dihydropyran fragment commenced with a Wittig, reduction, oxidation sequence of
aldehyde 17,5c available in two steps via a Myers alkylation,14 reduction sequence, to
provide trisubstituted olefin 19 in 92% yield over the three steps (Scheme 4). Exposure of
aldehyde 19 to a Brown alkyoxy-allylation15 delivered differentially protected syn-1,2-diol
20 in 96% yield. Upon treatment of the allylation adduct with acrolein diethyl acetal,16 an
intermediate diene was obtained, which underwent ring closing metathesis in the presence of
Grubbs 2nd generation catalyst (G2) to generate mixed acetal 21 as an inconsequential 1:1
mixture of diastereomers in 72% yield over two steps.17 Treatment of the mixed acetal with
BF3·OEt2 in the presence of allyl-trimethylsilane effected a Sakurai reaction to deliver
allylated product 5 in 92% yield as a single diastereomer.18 Introduction of the desired
oxidation state at C1 was achieved by a four step sequence5c involving cleavage of the PMB
ether under oxidative conditions, Dess-Martin oxidation,19 Pinnick oxidation,20 and finally
ester formation21 to afford C1-C15 dihydropyran 22 in 57% yield. The MOM ether was
exchanged for a TBS ether via a two step sequence to give rise to dihydropyran 23 in 93%
yield.
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With both cross metathesis partners in hand, bicyclic ether/THP fragment 16 and DHP 23
were exposed to Hoveyda-Grubbs 2nd generation catalyst (HG2). This key bond forming
reaction was complicated by the fact that both cross metathesis partners are Type I olefins,7
thus a statistical mixture of cross metathesis adduct 24 and the C16-C37 fragment 16 and
DHP 23 homodimers was expected; however, only a 16% yield of the desired cross
metathesis adduct was obtained. Despite the low yield for this key reaction, intermediate 24
was advanced through a three step sequence to arrive at C1-C38 fragment 2 in 31% yield.22
In light of the low yield obtained for the cross metathesis reaction to unite the DHP fragment
with the rest of the molecule, we decided to turn our attention toward the Julia-Kocienski
olefination used by Smith to form the C15-C16 bond.5a In order to prepare the bicyclic
ether/THP and dihydropyran fragments necessary for the Julia olefination, we needed to
modify our protecting group strategy and investigate an alternative cross metathesis/vinyl
addition sequence.
Attention was first turned toward synthesis of the modified bicyclic ether/THP fragment.
Toward this end, previously prepared bicyclic ether 36 was protected as the PMB-ether,
which upon oxidative cleavage by the Johnson-Lemieux protocol23 and methylene Wittig
olefination delivered bicyclic ether 25 (Scheme 5). To our delight, upon dropwise addition
of THP 4 to a solution of bicyclic ether 25 and Grubbs 2nd generation catalyst (G2), cross
metathesis adduct 26 was obtained in 77% yield as a single detectable E isomer. Exposure of
TES ether 26 to modified Swern conditions allowed for the selective oxidation of the C21
alcohol to generate an intermediate aldehyde, which upon treatment with the vinyl zinc
species formed from vinyl iodide 27, afforded bicyclic ether/THP fragment 28 in 64% yield
(two steps).
To arrive at C1-C38 fragment 2, several protecting group manipulations were necessary.
Toward this end, all of the silyl protecting groups from vinyl addition product 28 were
removed with TBAF to reveal an intermediate tetraol. The tetraol was subjected to CSA in
neat dimethoxypropane to effect acetonide formation, whereupon the C16 and C25 alcohols
were protected as TBS and MOM ethers respectively,24 furnishing the fully protected
bicyclic ether/THP fragment 29 in 45% yield over the four step sequence. Introduction of
the vinyl iodide moiety was next pursued. Cleavage of the PMB ether was achieved under
oxidative conditions with DDQ, and the resultant alcohol was oxidized under Dess-Martin
conditions. The resultant intermediate aldehyde was immediately utilized in a Takai
olefination22,25 to give rise to a 4:1 ratio of E/Z-vinyl iodides. The vinyl iodides were readily
separated by flash column chromatography to deliver E-vinyl iodide 30 in 28% yield over
the three steps. Vinyl iodide 30 was converted to aldehyde 31, required for the Julia-
Kocienski olefination, by a known two step sequence in 68% yield.5
With the aldehyde coupling partner in hand, we turned our attention to the synthesis of the
C1-C15 sulfone. This was achieved in an efficient manner upon modification of the
previously employed route towards dihydropyran 23. A Lewis-acid mediated addition of
acetaldehyde silyl ether to mixed acetal 21 delivered aldehyde 6 in 82% yield as a single
diasteromer (Scheme 6).26 Aldehyde 6 was reduced via a sodium borohydride reduction to
give rise to the C15 alcohol. The MOM ether was cleaved from the resultant alcohol under
acidic conditions to reveal an intermediate diol, which was converted to bis-TBS ether 32 in
83% yield over the three step sequence. Introduction of the desired oxidation state at C1 was
achieved via the previously used sequence,5c in which PMB-ether 32 was converted to tert-
butyl ester 33 in four steps and 72% yield. Ester 33 corresponds to an intermediate from
Smith's synthesis, thus a known three step sequence was carried out to selectively cleave the
C15 TBS-ether and convert the resultant alcohol to sulfone 34.5a Finally, sulfone 34 and
aldehyde 31 were employed in a Julia-Kocienski olefination,27 using the conditions
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described by Smith,5a to give rise to C1-C38 fragment 2 in 79% yield. Fragment 2 was
spectroscopically identical to that reported by Smith.5a
In summary, two routes towards the formal synthesis of the C1-C38 fragment of (+)-
sorangicin A (1) have been completed. Both routes feature a cross metathesis reaction to
unite the bicyclic ether and THP fragments. Our initial approach featured a second cross
metathesis to append the DHP fragment, however a low yield for this key reaction prompted
us to instead employ a Julia-Kocienski olefination to form the C15-C16 bond.
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Scheme 1. Synthetic approach toward (+)-sorangicin A (1)
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Scheme 2. Synthesis of tetrahydropyran 4
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Scheme 3. Cross metathesis to form bicyclic ether/THP fragment 16
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Scheme 4. Formal synthesis of C1-C38 fragment 2 via a cross metathesis approach
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Scheme 5. Cross metathesis to form bicyclic ether/THP fragment 31
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Scheme 6. Julia-Kocienski olefination approach to fragment 2
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